A braking system for immune responses: Researchers find receptor for uric acid crystals

March 20, 2014, Technical University Munich
Picture of uric acid crystals: Uric acid forms needle-like crystals which activate the immune system. Credit: K. Neumann/TUM

For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control immune responses. The team, led by researchers from Technische Universität München's Klinikum rechts der Isar hospital have published their findings in the Immunity journal.

The surface of is home to a number of receptors which are able to detect pathogens. As soon as these receptors are activated, inflammation occurs and the body's defense mechanisms kick in. Immune also have receptors that regulate or even suppress immunological responses to prevent damage to individual cells.

There are other immune receptors that recognize endogenous substances that are released when tissue damage or cell death occurs. As such, the organism can defend itself even in cases where the damage caused by the pathogen, but not the pathogen itself, is detected.

With the discovery of the surface molecule Clec12a from the family of C-type lectin receptors, the team led by Prof. Jürgen Ruland of Klinikum rechts der Isar have found the first known immune receptor for crystals. Uric acid is a break-down product of nucleic acids like DNA in response to cell damage. Whenever a large number of cells die, for example when a tumor is being medically treated or during an infection, the uric acid becomes more concentrated and the molecules crystallize.

Immune responses have to be regulated

Uric acid crystals also form when tissue is damaged and they boost the . However, Clec12a limits the immune response instead of increasing it. "Clec12a suppresses the response to dead cells and uric acid crystals," explains Prof. Ruland. "The immune system has evidently developed a mechanism to prevent an overreaction to the crystals."

The receptor Clec12a was stained with red dye and added to uric acid crystals. The red areas on the crystals indicate the binding of receptors. Credit: K. Neumann/TUM

Immune cells are capable of producing highly toxic substances which can damage healthy tissue as well as pathogens. "Uric acid crystals and other substances originating from damaged cells signal a potential danger to the immune system," says Dr. Konstantin Neumann, lead author of the study. "As long as no further indications of a genuine infection are found, Clec12a's role is to protect the organism from damage triggered by the immune system."

By discovering the immune receptor for uric acid crystals, the researchers have gained an understanding of the fundamental mechanism by which the immune system recognizes crystals. They intend to find out whether there are other receptors like Clec12a that are also capable of sensing crystalline structures. "In the future, we might discover better ways to regulate inflammation with crystal formation, or even use these mechanisms to manipulate the in a targeted way to treat tumors or infectious diseases," concludes Ruland.

Explore further: Immunology researchers uncover pathways that direct immune system to turn 'on' or 'off'

More information: Konstantin Neumann, Mercedes Castiñeiras-Vilariño, Ulrike Höckendorf, Nicole Hannesschläger, Simone Lemeer, Danny Kupka, Svenia Meyermann, Maciej Lech, Hans-Joachim Anders, Bernhard Kuster, Dirk H. Busch, Andreas Gewies, Ronald Naumann, Olaf Groß, Jürgen Ruland; Clec12a Is an Inhibitory Receptor for Uric Acid Crystals that Regulates Inflammation in Response to Cell Death, Immunity (2014), DOI: 10.1016/j.immuni.2013.12.015

Related Stories

Immunology researchers uncover pathways that direct immune system to turn 'on' or 'off'

March 18, 2014
(Medical Xpress)—A key discovery explaining how components of the immune system determine whether to activate or to suppress the immune system, made by Kelvin Lee, MD, Professor of Oncology and Co-Leader of the Tumor Immunology ...

Study could aid development of new drugs to treat gout

March 19, 2013
Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout. The study, led by Liang Qiao, MD, and his colleagues and collaborators, was published March ...

Researchers discover how cancer 'invisibility cloak' works

October 28, 2013
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, ...

Scarcity of fruit millions of years ago could have caused loss of enzyme that prevents gout

February 18, 2014
(Medical Xpress)—Apes, including humans, lack an enzyme called uricase that breaks down uric acid. Because we lack uricase, we are predisposed to developing gout. After reconstructing ancient versions of the enzyme found ...

Adding uric acid to standard stroke clot busters reduces stroke disability

February 13, 2014
Giving stroke patients uric acid along with standard clot-busting medication within 4.5 hours of first symptoms appears safe and effective at limiting disability, according to late-breaking science presented at the American ...

Recommended for you

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.